Yumiko K. Sugiyama

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Characteristic features of late-onset systemic lupus erythematosus: An observational study of data from the Lupus Registry of Nationwide Institutions.

Characteristic features of late-onset systemic lupus erythematosus: An observational study of data from the Lupus Registry of Nationwide Institutions.

Journal: Lupus

Published: September 03, 2024

Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis.

Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis.

Journal: Frontiers in immunology

Published: October 27, 2021

Anti-TRIM21 antibody is associated with aberrant B-cell function and type I interferon production in systemic lupus erythematosus.

Anti-TRIM21 antibody is associated with aberrant B-cell function and type I interferon production in systemic lupus erythematosus.

Journal: Lupus

Published: September 27, 2021

Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet's disease in Japan.

Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet's disease in Japan.

Journal: Arthritis research & therapy

Published: August 10, 2020

Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease.

Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: September 21, 2019

TRIM21 Dysfunction Enhances Aberrant B-Cell Differentiation in Autoimmune Pathogenesis.

TRIM21 Dysfunction Enhances Aberrant B-Cell Differentiation in Autoimmune Pathogenesis.

Journal: Frontiers in immunology

Published: September 06, 2019

miR-1 is a novel biomarker for polymyositis/dermatomyositis-associated interstitial lung disease.

miR-1 is a novel biomarker for polymyositis/dermatomyositis-associated interstitial lung disease.

Journal: Modern rheumatology

Published: September 05, 2019

Dose down-titration of biological disease-modifying antirheumatic drugs in daily clinical practice: Shared decision-making and patient treatment preferences in Japanese patients with rheumatoid arthritis.

Dose down-titration of biological disease-modifying antirheumatic drugs in daily clinical practice: Shared decision-making and patient treatment preferences in Japanese patients with rheumatoid arthritis.

Journal: International journal of rheumatic diseases

Published: June 26, 2019

Dysfunction of TRIM21 in interferon signature of systemic lupus erythematosus.

Dysfunction of TRIM21 in interferon signature of systemic lupus erythematosus.

Journal: Modern rheumatology

Published: February 02, 2018

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease.

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease.

Journal: Arthritis research & therapy

Published: October 27, 2017

Non-IgG4-related Multifocal Fibrosclerosis.

Non-IgG4-related Multifocal Fibrosclerosis.

Journal: Internal medicine (Tokyo, Japan)

Published: September 02, 2016

Musculoskeletal ultrasonography delineates ankle symptoms in rheumatoid arthritis.

Musculoskeletal ultrasonography delineates ankle symptoms in rheumatoid arthritis.

Journal: Modern rheumatology

Published: August 20, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026